KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Depreciation & Amortization (CF) (2016 - 2025)

Charles River Laboratories International has reported Depreciation & Amortization (CF) over the past 17 years, most recently at $78.3 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 23.34% year-over-year to $78.3 million; the TTM value through Dec 2025 reached $403.3 million, up 11.49%, while the annual FY2025 figure was $403.3 million, 11.49% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $78.3 million at Charles River Laboratories International, down from $85.2 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $120.4 million in Q1 2025 and troughed at $61.5 million in Q1 2021.
  • A 5-year average of $82.4 million and a median of $78.0 million in 2023 define the central range for Depreciation & Amortization (CF).
  • On a YoY basis, Depreciation & Amortization (CF) climbed as much as 41.01% in 2025 and fell as far as 23.34% in 2025.
  • Year by year, Depreciation & Amortization (CF) stood at $67.2 million in 2021, then rose by 15.32% to $77.5 million in 2022, then rose by 3.83% to $80.5 million in 2023, then rose by 26.82% to $102.1 million in 2024, then decreased by 23.34% to $78.3 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for CRL at $78.3 million in Q4 2025, $85.2 million in Q3 2025, and $119.5 million in Q2 2025.